Skip to main content
Log in

Ethyl eicosapentaenoic acid higher value in secondary prevention

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2020 US dollars

Reference

  • Arbel R, et al. Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia-Value for Money Analysis. American Journal of Medicine : 12 Jan 2021. Available from: URL: http://doi.org/10.1016/j.amjmed.2020.12.023

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ethyl eicosapentaenoic acid higher value in secondary prevention. PharmacoEcon Outcomes News 870, 6 (2021). https://doi.org/10.1007/s40274-021-7409-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7409-5

Navigation